Overview
This double arm, split-mouth, single centre, controlled, randomised clinical study is designed to examine the effect of implantoplasty in treatment of peri-implantitis.
Peri-implantitis will be treated with open flap debridement, with or without implantoplasty.
Eligibility
Inclusion Criteria:
- Peri-implantitis (according to 2018 criteria) on minimum 2 implants of similar surface and defect type
- Competent to give consent
- Exposed, modified implant surface with loss >2mm
Exclusion Criteria:
- Previous radiotherapy to the jaws, current use of chemotherapy, systemic long-term corticosteroid treatment
- Present or past use of bisphosphonate treatment • Pregnant or nursing subjects
- Patients classified as > class II according to ASA classification
- Implant unavailable for implantoplasty treatment
- Inhability to comprehend and respond to the quality of life questionnaire
- Examiners/operators deem original placement of implant (angle, position) suboptimal and considered to play a major role in development of peri-implantitis
- History of peri-implantitis surgery prior to 6 months of screening